Skip to main content

Cholesterol Ratio Calculator

Estimate your cholesterol ratio with our free metabolic disorders calculator. See reference ranges, risk factors, and next-step guidance.

Skip to calculator
Medicine & Health

Cholesterol Ratio Calculator

Calculate TC/HDL ratio, LDL/HDL ratio, Triglyceride/HDL ratio, and Atherogenic Index of Plasma. Assess cardiovascular risk with comprehensive lipid panel analysis.

Last updated: January 2026Reviewed by NovaCalculator Medical Editorial Team

Calculator

Adjust values & calculate
200
55
120
150
Overall Cardiovascular Risk
Low Risk
Based on combined cholesterol ratio analysis
TC/HDL Ratio
3.64
Average
LDL/HDL Ratio
2.18
Average
TG/HDL Ratio
2.73
Borderline
Atherogenic Index (AIP)
0.436
High Risk
Non-HDL Cholesterol
145 mg/dL
Target: <130 mg/dL
Calculated LDL (Friedewald)
115 mg/dL
Estimated VLDL
30 mg/dL

Optimal Ratio Targets

TC/HDL Ratio< 3.5 (women) / < 4.5 (men)
LDL/HDL Ratio< 2.5
TG/HDL Ratio< 2.0
AIP< 0.11
Medical Disclaimer: This calculator is for educational purposes only. Cholesterol ratios should be interpreted in the context of your complete cardiovascular risk profile including blood pressure, diabetes status, smoking history, and family history. Consult your healthcare provider for personalized lipid management recommendations.
Your Result
TC/HDL: 3.64 (Average) | LDL/HDL: 2.18 (Average) | TG/HDL: 2.73 | Overall: Low Risk
Share Your Result
Understand the Math

Formula

TC/HDL Ratio = Total Cholesterol / HDL; LDL/HDL Ratio = LDL / HDL; AIP = log10(TG/HDL)

Where TC/HDL ratio (Castelli Risk Index I) divides total cholesterol by HDL cholesterol, LDL/HDL ratio (Castelli Risk Index II) measures the balance of harmful to protective cholesterol, the Triglyceride/HDL ratio serves as a surrogate marker for insulin resistance, and AIP (Atherogenic Index of Plasma) is the base-10 logarithm of triglycerides divided by HDL, all values in mg/dL.

Last reviewed: January 2026

Worked Examples

Example 1: Favorable Lipid Profile Assessment

A patient has Total Cholesterol 190 mg/dL, HDL 65 mg/dL, LDL 100 mg/dL, and Triglycerides 120 mg/dL. Calculate all cholesterol ratios.
Solution:
TC/HDL Ratio = 190 / 65 = 2.92 (Optimal, below 3.5) LDL/HDL Ratio = 100 / 65 = 1.54 (Optimal, below 2.5) Triglyceride/HDL Ratio = 120 / 65 = 1.85 (Low insulin resistance) Non-HDL Cholesterol = 190 - 65 = 125 mg/dL VLDL = 120 / 5 = 24 mg/dL AIP = log10(120/65) = log10(1.85) = 0.266
Result: All ratios in optimal or near-optimal range. Low cardiovascular risk profile.

Example 2: High-Risk Lipid Profile with Metabolic Markers

A patient has Total Cholesterol 260 mg/dL, HDL 35 mg/dL, LDL 170 mg/dL, and Triglycerides 280 mg/dL. Assess cardiovascular risk.
Solution:
TC/HDL Ratio = 260 / 35 = 7.43 (Very High Risk) LDL/HDL Ratio = 170 / 35 = 4.86 (Very High Risk) Triglyceride/HDL Ratio = 280 / 35 = 8.0 (High insulin resistance) Non-HDL Cholesterol = 260 - 35 = 225 mg/dL (well above 130 target) VLDL = 280 / 5 = 56 mg/dL AIP = log10(280/35) = log10(8.0) = 0.903 (Very High Risk)
Result: All ratios indicate very high cardiovascular risk. Immediate lifestyle intervention and likely statin therapy indicated.
Expert Insights

Background & Theory

The Cholesterol Ratio Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/mยฒ), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 ร— weight in kg) + (6.25 ร— height in cm) โˆ’ (5 ร— age) ยฑ sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.

History

The history behind the Cholesterol Ratio Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.

Share this calculator

Explore More

Frequently Asked Questions

The cholesterol ratio (total cholesterol divided by HDL cholesterol) provides a more comprehensive assessment of cardiovascular risk than any single cholesterol measurement alone. Total cholesterol includes both protective HDL cholesterol and harmful LDL cholesterol, so a high total cholesterol with very high HDL may actually represent lower risk than moderate total cholesterol with very low HDL. The ratio captures this relationship by measuring the balance between atherogenic (artery-clogging) and anti-atherogenic (artery-protecting) lipoproteins. A ratio below 3.5 is considered optimal, while ratios above 5.0 indicate significantly increased cardiovascular risk. The American Heart Association considers the cholesterol ratio a useful tool for assessing relative risk.
The Friedewald equation estimates LDL cholesterol from other measured lipid values using the formula: LDL = Total Cholesterol - HDL - (Triglycerides / 5), where all values are in mg/dL. In mmol/L units, the divisor changes to 2.2 instead of 5. This equation works because total cholesterol equals the sum of LDL, HDL, and VLDL, and VLDL can be estimated as triglycerides divided by 5. The equation has important limitations: it becomes inaccurate when triglycerides exceed 400 mg/dL because the VLDL estimation breaks down, it underestimates LDL at very low levels, and it is unreliable in non-fasting samples. Direct LDL measurement is available but more expensive. Newer equations like the Martin-Hopkins formula improve accuracy at low LDL levels.
Non-HDL cholesterol is simply total cholesterol minus HDL cholesterol, and it represents all the atherogenic (artery-damaging) lipoproteins in the blood, including LDL, VLDL, IDL, and lipoprotein(a). Unlike LDL cholesterol, non-HDL cholesterol does not require fasting blood samples and is not affected by elevated triglycerides, making it more reliable across diverse clinical scenarios. Current guidelines from the European Society of Cardiology and others have elevated non-HDL cholesterol as a secondary treatment target, with goals of less than 130 mg/dL for moderate-risk patients and less than 100 mg/dL for high-risk patients. Non-HDL cholesterol is approximately 30 mg/dL higher than LDL cholesterol in most individuals and has been shown in meta-analyses to be a better predictor of cardiovascular events than LDL cholesterol alone.
Different dietary approaches affect cholesterol components and their ratios through distinct mechanisms. The Mediterranean diet (rich in olive oil, nuts, fish, and vegetables) typically improves HDL, lowers triglycerides, and reduces the TC/HDL ratio. Low-carbohydrate and ketogenic diets often dramatically reduce triglycerides and improve the triglyceride/HDL ratio but may increase total and LDL cholesterol. Plant-based diets tend to lower total and LDL cholesterol significantly but may also modestly reduce HDL. The DASH diet reduces total and LDL cholesterol while maintaining HDL levels. Replacing saturated fats with unsaturated fats generally improves the LDL/HDL ratio. Adding soluble fiber (oats, beans, barley) reduces LDL without affecting HDL, improving all ratios. The optimal dietary approach depends on which specific lipid abnormality predominates in each individual.
Treatment decisions should not be based solely on cholesterol ratios but should consider overall cardiovascular risk using validated risk calculators like the ACC/AHA Pooled Cohort Equation or the European SCORE system. However, as general guidelines, a TC/HDL ratio consistently above 5.0, an LDL/HDL ratio above 3.5, or a triglyceride/HDL ratio above 3.5 in the context of other cardiovascular risk factors typically warrants discussion about statin therapy or other lipid-lowering medications. Statins are the first-line treatment for elevated LDL cholesterol and improve cholesterol ratios by lowering LDL 30-50% while modestly raising HDL. For patients with persistent triglyceride elevation, omega-3 fatty acids (icosapent ethyl/Vascepa) or fibrates may be added. Lifestyle modifications should be attempted for at least 3-6 months before initiating medication in patients without established cardiovascular disease.
You may use the results for reference and educational purposes. For professional reports, academic papers, or critical decisions, we recommend verifying outputs against peer-reviewed sources or consulting a qualified expert in the relevant field.
Educational Note: This calculator is provided for educational and informational purposes. Results are based on the formulas and inputs provided. Always verify important calculations independently. NovaCalculator processes calculator inputs client-side; optional analytics follow visitor consent settings.Reviewed by: NovaCalculator Medical Editorial Team โ€” Reviewed against WHO, NIH, and peer-reviewed clinical sources. Last reviewed: January 2026. ยฉ 2024โ€“2026 NovaCalculator.

Share this calculator

Formula

TC/HDL Ratio = Total Cholesterol / HDL; LDL/HDL Ratio = LDL / HDL; AIP = log10(TG/HDL)

Where TC/HDL ratio (Castelli Risk Index I) divides total cholesterol by HDL cholesterol, LDL/HDL ratio (Castelli Risk Index II) measures the balance of harmful to protective cholesterol, the Triglyceride/HDL ratio serves as a surrogate marker for insulin resistance, and AIP (Atherogenic Index of Plasma) is the base-10 logarithm of triglycerides divided by HDL, all values in mg/dL.

Worked Examples

Example 1: Favorable Lipid Profile Assessment

Problem: A patient has Total Cholesterol 190 mg/dL, HDL 65 mg/dL, LDL 100 mg/dL, and Triglycerides 120 mg/dL. Calculate all cholesterol ratios.

Solution: TC/HDL Ratio = 190 / 65 = 2.92 (Optimal, below 3.5)\nLDL/HDL Ratio = 100 / 65 = 1.54 (Optimal, below 2.5)\nTriglyceride/HDL Ratio = 120 / 65 = 1.85 (Low insulin resistance)\nNon-HDL Cholesterol = 190 - 65 = 125 mg/dL\nVLDL = 120 / 5 = 24 mg/dL\nAIP = log10(120/65) = log10(1.85) = 0.266

Result: All ratios in optimal or near-optimal range. Low cardiovascular risk profile.

Example 2: High-Risk Lipid Profile with Metabolic Markers

Problem: A patient has Total Cholesterol 260 mg/dL, HDL 35 mg/dL, LDL 170 mg/dL, and Triglycerides 280 mg/dL. Assess cardiovascular risk.

Solution: TC/HDL Ratio = 260 / 35 = 7.43 (Very High Risk)\nLDL/HDL Ratio = 170 / 35 = 4.86 (Very High Risk)\nTriglyceride/HDL Ratio = 280 / 35 = 8.0 (High insulin resistance)\nNon-HDL Cholesterol = 260 - 35 = 225 mg/dL (well above 130 target)\nVLDL = 280 / 5 = 56 mg/dL\nAIP = log10(280/35) = log10(8.0) = 0.903 (Very High Risk)

Result: All ratios indicate very high cardiovascular risk. Immediate lifestyle intervention and likely statin therapy indicated.

Frequently Asked Questions

What is the cholesterol ratio and why is it considered more important than total cholesterol alone?

The cholesterol ratio (total cholesterol divided by HDL cholesterol) provides a more comprehensive assessment of cardiovascular risk than any single cholesterol measurement alone. Total cholesterol includes both protective HDL cholesterol and harmful LDL cholesterol, so a high total cholesterol with very high HDL may actually represent lower risk than moderate total cholesterol with very low HDL. The ratio captures this relationship by measuring the balance between atherogenic (artery-clogging) and anti-atherogenic (artery-protecting) lipoproteins. A ratio below 3.5 is considered optimal, while ratios above 5.0 indicate significantly increased cardiovascular risk. The American Heart Association considers the cholesterol ratio a useful tool for assessing relative risk.

How is LDL cholesterol calculated using the Friedewald equation?

The Friedewald equation estimates LDL cholesterol from other measured lipid values using the formula: LDL = Total Cholesterol - HDL - (Triglycerides / 5), where all values are in mg/dL. In mmol/L units, the divisor changes to 2.2 instead of 5. This equation works because total cholesterol equals the sum of LDL, HDL, and VLDL, and VLDL can be estimated as triglycerides divided by 5. The equation has important limitations: it becomes inaccurate when triglycerides exceed 400 mg/dL because the VLDL estimation breaks down, it underestimates LDL at very low levels, and it is unreliable in non-fasting samples. Direct LDL measurement is available but more expensive. Newer equations like the Martin-Hopkins formula improve accuracy at low LDL levels.

What is non-HDL cholesterol and why do guidelines increasingly emphasize it?

Non-HDL cholesterol is simply total cholesterol minus HDL cholesterol, and it represents all the atherogenic (artery-damaging) lipoproteins in the blood, including LDL, VLDL, IDL, and lipoprotein(a). Unlike LDL cholesterol, non-HDL cholesterol does not require fasting blood samples and is not affected by elevated triglycerides, making it more reliable across diverse clinical scenarios. Current guidelines from the European Society of Cardiology and others have elevated non-HDL cholesterol as a secondary treatment target, with goals of less than 130 mg/dL for moderate-risk patients and less than 100 mg/dL for high-risk patients. Non-HDL cholesterol is approximately 30 mg/dL higher than LDL cholesterol in most individuals and has been shown in meta-analyses to be a better predictor of cardiovascular events than LDL cholesterol alone.

How do different dietary patterns affect cholesterol ratios?

Different dietary approaches affect cholesterol components and their ratios through distinct mechanisms. The Mediterranean diet (rich in olive oil, nuts, fish, and vegetables) typically improves HDL, lowers triglycerides, and reduces the TC/HDL ratio. Low-carbohydrate and ketogenic diets often dramatically reduce triglycerides and improve the triglyceride/HDL ratio but may increase total and LDL cholesterol. Plant-based diets tend to lower total and LDL cholesterol significantly but may also modestly reduce HDL. The DASH diet reduces total and LDL cholesterol while maintaining HDL levels. Replacing saturated fats with unsaturated fats generally improves the LDL/HDL ratio. Adding soluble fiber (oats, beans, barley) reduces LDL without affecting HDL, improving all ratios. The optimal dietary approach depends on which specific lipid abnormality predominates in each individual.

At what cholesterol ratio values should medication be considered?

Treatment decisions should not be based solely on cholesterol ratios but should consider overall cardiovascular risk using validated risk calculators like the ACC/AHA Pooled Cohort Equation or the European SCORE system. However, as general guidelines, a TC/HDL ratio consistently above 5.0, an LDL/HDL ratio above 3.5, or a triglyceride/HDL ratio above 3.5 in the context of other cardiovascular risk factors typically warrants discussion about statin therapy or other lipid-lowering medications. Statins are the first-line treatment for elevated LDL cholesterol and improve cholesterol ratios by lowering LDL 30-50% while modestly raising HDL. For patients with persistent triglyceride elevation, omega-3 fatty acids (icosapent ethyl/Vascepa) or fibrates may be added. Lifestyle modifications should be attempted for at least 3-6 months before initiating medication in patients without established cardiovascular disease.

How accurate are the results from Cholesterol Ratio Calculator?

All calculations use established mathematical formulas and are performed with high-precision arithmetic. Results are accurate to the precision shown. For critical decisions in finance, medicine, or engineering, always verify results with a qualified professional.

References

Reviewed by Rahul Singh, Health & Wellness Specialist ยท Editorial policy